Submitted by kzahs_258301 on Tue, 05/22/2018 - 5:51pm NCT02907567 CT1812 Australia Thursday, September 1, 2016 – Thursday, August 24, 2017 19 Phase 1/2 Alzheimer's Disease Tuesday, May 22, 2018 Cognition Therapeutics Inc. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by kzahs_258301 on
Submitted by kzahs_258301 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.